Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed objectives and criteria for a clinical study on BIVV001, while adding new identifiers and a revision number.SummaryDifference8%
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.4%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.4%
Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.